Management cannot wait until the fourth quarter to replenish the balance sheet, as shares will come under heavy pressure as cash slips below $10 million. In an ideal world, management would secure a key partnership that brings in cash on a non-dilutive basis. The alternative of having another secondary while the stock trades around $2 is not an attractive prospect. Celsion's share count, at a recent 33 million, has already more than doubled from a year ago. Further dilution can only make the stock sink further as the all-important end to the HEAT trial approaches.
This seems to be a plausible explanation for why the stock continues to languish at these levels. The market could be expecting another capital raise.Certainly could happen. But given the continues insider buying, I think that possibility not so likely and, even if if happened, IF Tdox works, we'll easily climb to double digits...if not almost immediately, then in relatively short order... 6 nmonths or less. JMHOAISTI